Filter News
Area of Research
- (-) Nuclear Science and Technology (1)
- Advanced Manufacturing (3)
- Biological Systems (1)
- Biology and Environment (39)
- Clean Energy (56)
- Computational Biology (1)
- Computational Engineering (1)
- Computer Science (1)
- Electricity and Smart Grid (1)
- Fusion and Fission (4)
- Fusion Energy (1)
- Isotopes (7)
- Materials (72)
- Materials Characterization (2)
- Materials for Computing (8)
- Materials Under Extremes (1)
- National Security (19)
- Neutron Science (24)
- Supercomputing (58)
News Type
Date
News Topics
- (-) Biomedical (1)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (6)
- Bioenergy (1)
- Computer Science (2)
- Coronavirus (1)
- Decarbonization (1)
- Fusion (7)
- Isotopes (4)
- Materials Science (3)
- Molten Salt (1)
- Neutron Science (2)
- Nuclear Energy (23)
- Physics (2)
- Space Exploration (3)
- Sustainable Energy (1)
- Transformational Challenge Reactor (3)
Media Contacts
![Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227. Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227.](/sites/default/files/styles/list_page_thumbnail/public/2016-P07827%5B1%5D.jpg?itok=yJbnFQLU)
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.